Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05596409 |
|---|---|
| Brief Title: | ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer Study (ELCIN) |
| First Submitted : | October 24, 2022 |
| First Submitted that Met QC Criteria : | October 24, 2022 |
| First Posted : | October 27, 2022 |
| Last Update Submitted that Met QC Criteria : | May 16, 2024 |
| Last Update Posted : | May 17, 2024 |